These included generalized edema, pain, nasopharyngitis, oral candidiasis, urinary tract infection, alanine aminotransferase elevation, fluid retention, and insomnia in the RCI group, and injection site inflammation and headache in the placebo group. The gene discussed is GPT; the disease is nasopharyngitis.